ZVRA
Companies
NASDAQ
Zevra Therapeutics Inc.
Health Care
$9.00
+$0.66 (+7.91%)
Price Chart
Overview
About ZVRA
kempharm is a biopharmaceutical company focused on the discovery and development of new chemical entities (nces) to treat serious medical conditions through its proprietary and broadly applicable ligand activated therapy (lat) approach. the company utilizes its lat technology to generate improved prodrug versions of fda approved drugs in the high needs areas of pain, adhd and other cns diseases.
Market Cap
$194.6M
Volume
6.4M
Avg. Volume
5.2M
P/E Ratio
-22.205128
Dividend Yield
0.00%
Employees
52.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.81
Moderate Correlation
Volatility
High (0.58)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, ZVRA shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025